Skip to main content

Funding Strategy: Fiscal Year 2017


In general, grants will be funded in priority score or percentile order. Additional considerations will include program relevance and need, the National Center for Complementary and Integrative Health’s (NCCIH) strategic priorities, duplication of ongoing research, availability of funds, and recommendations by the National Advisory Council for Complementary and Integrative Health (NACCIH). NCCIH will give additional consideration to applications from first-time R01 investigators (“new” and/or “early stage” investigators as defined by the National Institutes of Health [NIH]).

Budget Data

Future Year Commitments of FY 2017 New and Competing Renewal Awards

NCCIH’s funding policy is to award competing research project grants (RPGs) in accordance with the NIH Fiscal Policy for Grant Awards—FY 2017.

Duration of NCCIH’s Grants

Competing awards are adjusted to achieve a 4-year average duration for research project grants. Grants to early stage investigators, program project grants, and clinical trial grants are usually funded for the full length of their Council-recommended project period.

New and Early Stage Investigators

NCCIH will continue to help new and early stage investigators by seeking to equalize the success rates of new/early stage investigators and established investigators for new competing (Type 1) R01 and first renewal (Type 2) applications, in accordance with NIH guidelines as described at NIH Fiscal Policy for Grant Awards—FY 2017 and at New and Early Stage Investigator Policies.

Research Funding Guidelines

NCCIH will use the following guidelines for funding research project grants:

New Research Project Grants

NCCIH policy for new grants is to award them at the NACCIH-recommended level except for specific programmatic and administrative adjustments. All applications that do not exceed $250,000 in direct costs in any given year of support in the recommended competitive segment will be awarded under the modular concept. Applications requesting direct costs that exceed $250,000 in any year of support in the recommended competitive segment will be awarded with categorical budgets.

Program Project Grants (Type 1 and Type 2)

Type 1: The direct cost award will not exceed $1,250,000. Facilities and Administrative (F&A) costs associated with first-tier subcontracts are not included in the direct-cost ceiling. Annual increases for recurring costs in noncompeting years are not allowed.

Type 2: Direct costs will be awarded at the same amount shown on the Notice of Award for the last noncompetitive segment. As with new awards, annual increases for recurring costs are not allowed.

Modular to Modular

For competing renewal and MERIT extension grants that were modular awards in the preceding competitive segment and will be no more than $250,000 in direct costs in any given year of the recommended competitive segment, NCCIH will award at the NACCIH-recommended direct cost amount except for specific programmatic and administrative adjustments. F&A costs for first-tier consortia are not considered in the direct-cost base when calculating the maximum that can be requested.

Continuation Awards (Type 5 Noncompeting Renewal)

NCCIH will award Type 5 research and nonresearch grants in FY 2017 at 100 percent of the commitment level. Awards previously issued will be revised in accordance with this policy. Noncompeting awards will be issued without cost of living/inflationary adjustments in FY 2017; however, adjustments for special needs (such as equipment and added personnel) will continue to be accommodated. This policy applies to both modular and nonmodular grants.

Ruth L. Kirschstein National Research Service Awards (NRSA)

Consistent with the Consolidated Appropriations Act, 2014, and with the recommendations of the Advisory Committee to the Director regarding the Biomedical Research Workforce, NCCIH follows NIH policy for NRSA fellowships. The full range of stipend adjustments for FY 2017 is described in NOT-OD-17-084.